Pancreatic Cancer Research

ResearcherNational Cheng Kung University HospitalActive in the last 2 years

Ying‐Jui Chao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2345-4702; OpenAlex author ID A5043327266, A5158154062. Sources: OpenAlex.

Their work

Papers
16 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 16

  1. TBC1D23 drives lymphatic metastasis in pancreatic ductal adenocarcinoma by altering EGFR cell surface dynamics and signaling. Co-author DOI 10.1007/s13402-026-01203-8↗
  2. Drastic muscle wasting following surgery is a strong predictor of prognosis in early-stage pancreatic cancer-a Taiwanese multicenter cohort study. Co-author DOI 10.1016/j.ctarc.2026.101468↗
  3. A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC. Co-author DOI 10.1158/1078-0432.ccr-25-4564↗
  4. Outcomes of conversion surgery following chemotherapy for initially unresectable metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study in T… Co-author DOI 10.1007/s00432-025-06353-0↗
  5. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Co-author DOI 10.1186/s12929-024-01008-7↗
  6. The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study. First author DOI 10.1097/js9.0000000000000495↗
  7. Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: a prospective cohort study. Co-author DOI 10.1177/17588359221106558↗
  8. The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers14133137↗
  9. Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: a single institution experience. Co-author PMID 35693078↗
  10. No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol. Co-author DOI 10.1038/s41598-021-94111-w↗
  11. Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan. Co-author DOI 10.1186/s12929-020-00664-9↗
  12. Low CD8⁺ T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44⁺/CD133⁺ Cancer Stem Cells and Predict an Unfavorable Prognosis in Panc… First author DOI 10.3390/cancers11040541↗
  13. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8. Co-author DOI 10.7150/thno.36830↗
  14. Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes. Co-author DOI 10.3390/jcm7120502↗
  15. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal … First author DOI 10.1002/cncr.28774↗
  16. Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy. Co-author DOI 10.1186/1471-2482-14-72↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan‐Shen Shan · 14 shared papers, 2014–2026 · strength 2.18
  2. Nai‐Jung Chiang · 8 shared papers, 2020–2026 · strength 1.24
  3. Ya‐Chin Hou · 7 shared papers, 2014–2026 · strength 1.05
  4. Li‐Tzong Chen · 7 shared papers, 2019–2026 · strength 0.99
  5. Hao‐Chen Wang · 6 shared papers, 2014–2026 · strength 0.81
  6. Chien‐Jui Huang · 5 shared papers, 2022–2024 · strength 0.80
  7. Hui‐Jen Tsai · 5 shared papers, 2020–2026 · strength 0.73
  8. Yung‐Yeh Su · 4 shared papers, 2022–2026 · strength 0.70
  9. Ping‐Jui Su · 3 shared papers, 2022–2025 · strength 0.60
  10. Ting‐Kai Liao · 3 shared papers, 2022–2025 · strength 0.60
  11. Siao Muk Cheng · 2 shared papers, 2024–2026 · strength 0.41
  12. Tai‐Jan Chiu · 2 shared papers, 2019–2026 · strength 0.36
  13. Yan-Shen Shan · 1 shared paper, 2026 · strength 0.27
  14. Chien-Yu Chen · 1 shared paper, 2026 · strength 0.27
  15. Chia‐Ming Yeh · 1 shared paper, 2026 · strength 0.24
  16. Jeffrey Shu-Ming Chang · 2 shared papers, 2020–2021 · strength 0.20
  17. Po-Hsien Huang · 1 shared paper, 2019 · strength 0.09
  18. Yan-Shen Shan · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.